According to the Office of Drug Control, Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021 has been has been introduced to Parliament to streamline efficiency around license and permit applications.
The Bill will amend the Narcotic Drugs Act 1967 to support the implementation of a number of the recommendations of the Final Report of the Review of the Narcotic Drugs Act 1967 carried out recently by Professor John McMillan AO.
The Bill supports an innovative Australian medicinal cannabis industry for the benefit of Australian patients by:
reducing the burden of the license assessment process, by providing for a single medicinal cannabis license to replace the current suite of licenses required for cultivation, production, manufacture and research activities;
providing greater certainty to businesses and reducing duplicating processes by providing for the majority of licenses to be permanent; and
reaffirming the Australian government’s commitment to patient availability of safe, legal and sustainable supply of cannabis derived medicines.
Find out more here Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021